Trade Insulet Corporation - PODD CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.19 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 275.77 |
| Open | 279.95 |
| 1-Year Change | 37.07% |
| Day's Range | 275.95 - 280.15 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 275.95 | -3.00 | -1.08% | 278.95 | 281.88 | 275.81 |
| Jan 17, 2025 | 275.71 | 0.22 | 0.08% | 275.49 | 278.03 | 272.81 |
| Jan 16, 2025 | 272.68 | 9.23 | 3.50% | 263.45 | 274.82 | 263.43 |
| Jan 15, 2025 | 264.09 | -4.99 | -1.85% | 269.08 | 270.04 | 263.15 |
| Jan 14, 2025 | 266.92 | -1.28 | -0.48% | 268.20 | 270.08 | 262.92 |
| Jan 13, 2025 | 267.94 | -2.51 | -0.93% | 270.45 | 270.45 | 261.02 |
| Jan 10, 2025 | 271.36 | 4.47 | 1.67% | 266.89 | 274.17 | 265.95 |
| Jan 8, 2025 | 270.29 | 7.41 | 2.82% | 262.88 | 271.02 | 261.78 |
| Jan 7, 2025 | 265.60 | -1.79 | -0.67% | 267.39 | 269.02 | 263.89 |
| Jan 6, 2025 | 268.41 | 2.16 | 0.81% | 266.25 | 269.82 | 265.03 |
| Jan 3, 2025 | 266.16 | 9.34 | 3.64% | 256.82 | 267.35 | 256.82 |
| Jan 2, 2025 | 256.77 | -2.09 | -0.81% | 258.86 | 263.04 | 255.11 |
| Dec 31, 2024 | 261.01 | -2.27 | -0.86% | 263.28 | 264.64 | 259.29 |
| Dec 30, 2024 | 263.31 | 1.08 | 0.41% | 262.23 | 263.98 | 258.85 |
| Dec 27, 2024 | 265.02 | 2.76 | 1.05% | 262.26 | 265.79 | 261.95 |
| Dec 26, 2024 | 265.48 | 4.95 | 1.90% | 260.53 | 265.97 | 260.53 |
| Dec 24, 2024 | 263.17 | 1.07 | 0.41% | 262.10 | 263.87 | 261.18 |
| Dec 23, 2024 | 263.20 | -1.48 | -0.56% | 264.68 | 265.45 | 258.84 |
| Dec 20, 2024 | 266.34 | 9.94 | 3.88% | 256.40 | 270.45 | 256.40 |
| Dec 19, 2024 | 256.54 | 0.15 | 0.06% | 256.39 | 258.67 | 254.64 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Insulet Corporation Company profile
About Insulet Corporation
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Insulet Corporation revenues increased 21% to $1.1B. Net income increased from $6.8M to $16.8M. Revenues reflect Omnipod System segment increase of 24% to $651.5M, International Omnipod segment increase of 17% to $359.9M, United States segment increase of 24% to $738.9M, All Other segment increase of 17% to $359.9M. Net income benefited from IE on Capital Financing decrease of 13% to $36.7M (expense).
Equity composition
Common Stock, $.001 Par, 03/12, 100M auth., 45,670,320 issd. Insiders own 0.45%. IPO: 5/07, 7.7M shs.@ $15 per share by JPMorgan, Merrill Lynch & Co., Thomas Weisel Partners LLC and Leerink Swann & Company. PO:11/07, 4.9M shs. @ $23.25 per share by JP Morgan and Merrill Lynch.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Nagog Park
ACTON
MASSACHUSETTS 01720-3440
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com